- Home
- / Sun Pharma
Sun Pharma
Stock Price
₹1.9 K
2024-10-29
Market Capitalization
₹4.5 T
2024-10-29
Revenue
₹582.2 B
FY, 2026
Sun Pharma Summary
Company Summary
- Overview
- Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. Its product portfolio includes generics, over-the-counter drugs, anti-retrovirals (ARVs), active pharmaceutical ingredients, and intermediates.
- Type
- Public
- Status
- Active
- Founded
- 1983
- HQ
- Mumbai, IN | view all locations
- Website
- https://sunpharma.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Gautam Doshi, Independent Director
Pawan Goenka, Lead Independent Director
Rama Bijapurkar, Independent Director
Operating MetricsView all
ANDAs Approved to Date
542
2.1%
FY, 2025
NDA/BLA Filed to Date
70
7.7%
FY, 2025
NDA/BLA Approved to Date
57
11.8%
FY, 2025
LocationsView all
37 locations detected
Mumbai, MH HQ
India
SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E)
Billerica, MA
United States
29 Dunham Rd
East Windsor, NJ
United States
1 Commerce Dr
Princeton, NJ
United States
2 Independence Way
Macquarie Park, NSW
Australia
2.02/12 Waterloo Rd
Dhaka, Dhaka Division
Bangladesh
14th Floor (West Side) Police Plaza Concord (Tower – B) Gulshan-1
Sun Pharma Financials
Summary Financials
- Revenue (FY, 2026)
- ₹582.2B
- Gross profit (FY, 2026)
- ₹488.9B
- Net income (FY, 2026)
- ₹115.6B
- Cash (FY, 2026)
- ₹116.0B
- EBIT (FY, 2026)
- ₹142.2B
- Enterprise value
- $4.5T